Trials / Conditions / Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome (IBS)

71 registered clinical trials studyying Irritable Bowel Syndrome (IBS) — 28 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Mindfulness Training Versus Low (FODMAP) Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Poly NCT05630703	Wake Forest University Health Sciences	N/A
Not Yet Recruiting	Synbiotic Supplement With Botanical Extracts for Gut Microbiota Balance in Irritable Bowel Syndrome NCT07475299	Iuliu Hatieganu University of Medicine and Pharmacy	N/A
Recruiting	Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bo NCT07481422	University of Rijeka	Phase 1 / Phase 2
Not Yet Recruiting	New Microbiota-endocrine Axis in Fructose Malabsorption-caused Visceral Hypersensitivity in Irritable Bowel Sy NCT07337707	University Hospital, Rouen	N/A
Recruiting	Evaluating the Added Benefit of Osteopathic Care to a Flexi-FODMAP Diet in Fibromyalgia Patients With Irritabl NCT07176078	Universitair Ziekenhuis Brussel	N/A
Not Yet Recruiting	Feasibility Study of a Guided Imagery Therapy Mobile Application for Functional Abdominal Pain Disorders in Ch NCT07222943	Baylor College of Medicine	N/A
Recruiting	Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics NCT07261826	Chen QiYi	—
Not Yet Recruiting	Probiotic Mixture (L. Rhamnosus GG and L. Plantarum 299V) In Pediatric Irritable Bowel Syndrome NCT07125625	University of Bari	N/A
Not Yet Recruiting	A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Ir NCT06948461	PharmaPlanter Technologies Inc	Phase 2
Recruiting	Mechanism of FODMAP Restriction on FGID Patients NCT07000227	Universiti Kebangsaan Malaysia Medical Centre	N/A
Completed	Efficacy of Guided Imagery Therapy Mobile Application for Functional Abdominal Pain NCT06653647	Baylor College of Medicine	N/A
Not Yet Recruiting	Deep Learning-Based Confocal Laser Microendoscopy Feature Atlas Construction and Its Application in Intelligen NCT07051226	Daping Hospital and the Research Institute of Surgery of the Third Military Medical University	—
Completed	A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome NCT06676488	Medical University of South Carolina	N/A
Not Yet Recruiting	Diagnostic Study for Differentiating Functional From Organic Diseases in Patients With Lower GIT Symptoms NCT07016529	Sohag University	—
Recruiting	Exclude or Expose in Irritable Bowel Syndrome: What Works for Whom and How? NCT06940596	University of Melbourne	N/A
Enrolling By Invitation	Enabling Microbiomics- Driven Personalized Nutrition NCT06657001	Mayo Clinic	—
Not Yet Recruiting	Effect of a Low FODMAP Diet in IBS and Functional Constipation with Bloating: a Randomized Double-Blind Trial NCT06871748	Mahidol University	N/A
Not Yet Recruiting	Investigating the Gut Microbiome and Symptomology in IBS NCT06708533	Nottingham Trent University	N/A
Recruiting	Evaluate the Effect of Synbiotics in Irritable Bowel Syndrome NCT06647043	Universiti Sains Malaysia	N/A
Not Yet Recruiting	Pentabiocel in Pediatric IBS NCT06720805	University of Roma La Sapienza	N/A
Recruiting	Irritable Bowel Syndrome and Control Volunteers: Diet Challenge NCT06668922	University of California, Los Angeles	N/A
Recruiting	Prospective Observational Study of Naturopathic Approaches to IBS NCT06721624	National University of Natural Medicine	—
Recruiting	Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome NCT06681012	Devintec Sagl	N/A
Not Yet Recruiting	Effectiveness of Thyme in the Management of Clinical Symptoms in Patients with Irritable Bowel Syndrome NCT06609746	Shahid Beheshti University of Medical Sciences	N/A
Completed	Curcumin, Vitamin D and Green Tea in IBS-D NCT07052890	Dr Anthony Hobson	N/A
Recruiting	GWAS to Identify Predictive Genetic Factors for the Success of Dietary Intervention in the Treatment of IBS Sy NCT06912828	Attikon Hospital	—
Active Not Recruiting	Genetic Carbohydrate Maldigestion as a Model to Study Food Hypersensitivity NCT05795049	Nottingham University Hospitals NHS Trust	—
Recruiting	VICO-trial: Video Consultations in the Follow-up of Children With Functional Abdominal Pain Disorders NCT06665867	Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	N/A
Completed	Exercise and Vagus Nerve Stimulation in IBS NCT06769516	Bahçeşehir University	N/A
Completed	Enteric-Coated Peppermint Oil Versus Standard Antispasmodic in SLC6A4 (5-HTTLPR) Carriers With Irritable Bowel NCT06914921	S.LAB (SOLOWAYS)	N/A
Terminated	Feasibility of an Online Cognitive Behavioural Therapy Application (Mahana IBS™, Mahana Therapeutics) in the M NCT07008404	Nottingham University Hospitals NHS Trust	N/A
Unknown	Efficacy and Safety of Dietary Supplementation of Diamine Oxidase to Improve Symptoms in Patients With IBS NCT06139744	Nanjing First Hospital, Nanjing Medical University	Phase 4
Recruiting	Diet and Motility in IBS NCT07283341	Children's Hospital of Philadelphia	—
Completed	Exercise and Irritable Bowel Syndrome (IBS) NCT05453084	Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis	N/A
Enrolling By Invitation	Study on Treatment Mechanisms and Efficacy Prediction of Individualized Transcranial Magnetic Stimulation in A NCT07345377	The Affiliated Hospital of Hangzhou Normal University	N/A
Enrolling By Invitation	Quest to Analyze One Thousand Humans Meditating NCT06583395	Tobias Moeller-Bertram	—
Completed	The Effect of Inulin in Irritable Bowel Syndrome NCT06610188	Mardin Artuklu University	N/A
Unknown	Butyrate in Children With IBS: Double Blind Placebo Controlled Randomized Clinical Trial NCT04566679	University of Bari	N/A
Completed	Evaluate the Safety of Linaclotide in IBS-C Patients in China NCT04462900	AstraZeneca	—
Suspended	A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease NCT04031469	ProgenaBiome	—
Completed	Effect of Different Dietary Therapies on Intestinal Barrier Integrity in Patients With Irritable Bowel Syndrom NCT06421922	Gulhane Training and Research Hospital	N/A
Completed	Effect of HMOs as Nutritional Support for Normal Bowel Movements in IBS Patients NCT03550742	Glycom, Inc.	N/A
Completed	Mode of Action of Butyrate in the Human Colon NCT05249023	Örebro University, Sweden	N/A
Completed	Irritable Bowel Syndrome Survey in Gastroenterological Adult Outpatients in China NCT02955316	AstraZeneca	—
Completed	qQ-lab Daily-IBS for Irritable Bowel Syndrome NCT03964103	IlDong Pharmaceutical Co Ltd	N/A
Completed	Effects of HMOs on Faecal Microbiota, Gastrointestinal Symptoms, Mucosal Immunity and Barrier Function in IBS NCT02875847	Glycom A/S	Phase 2
Withdrawn	Genetic Determinism of Epithelial Barrier Defects in Irritable Bowel Syndrome NCT02841878	Centre Hospitalier Universitaire de Nice	N/A
Completed	Confocal Endomicroscopy Utility (p-CLE) in Irritable Bowel Syndrome NCT02651532	Instituto Ecuatoriano de Enfermedades Digestivas	—
Recruiting	Indiana University Gastrointestinal Motility Diagnosis Registry NCT04506593	Indiana University	—
Completed	Microbiome Fructan Metabolism and Symptoms in Childhood IBS NCT02842281	Baylor College of Medicine	N/A
Completed	Cognitive Behavior Therapy (CBT) for Children With Functional Gastrointestinal Disorders NCT02113605	Karolinska Institutet	N/A
Withdrawn	Collaborative Cognitive Behavioral Therapy / Hypnotherapy for Treatment of Pediatric Functional Gastrointestin NCT01966341	Seton Healthcare Family	N/A
Completed	Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter Trial NCT01908465	KU Leuven	Phase 4
Completed	Fecal Microbiota Transplantation in Patients With Irritable Bowel Syndrome NCT02092402	Örebro University, Sweden	N/A
Terminated	Study to Evaluate the Effects of ONO-2952 on Pain Perception Produced by Rectal Distention in Female Subjects NCT01887002	Ono Pharma USA Inc	Phase 2
Completed	A Phase 2, Multi-center Study to Evaluate the Efficacy and Safety of ONO-2952 in Female Subjects With Diarrhea NCT01844180	Ono Pharma USA Inc	Phase 2
Completed	The Diagnostic Predictability of Food Allergy Testing NCT01791621	The Canadian College of Naturopathic Medicine	N/A
Completed	Physical Activity in IBS - a Long Term Follow up NCT01774695	Sahlgrenska University Hospital	N/A
Completed	Microbe-Gut Interaction in Microscopic Colitis and Post-Infectious Irritable Bowel Syndrome (IBS) NCT01787253	Örebro University, Sweden	—
Completed	Abdominal Symptom Phenotype Study in Children NCT01204515	Baylor College of Medicine	—
Completed	Peer Mentorship: An Intervention To Promote Effective Pain Self-Management In Adolescents NCT01118988	University of California, Los Angeles	N/A
Completed	Tolerability and Effectiveness of Progut in Treatment of Irritable Bowel Syndrome NCT00904696	National University Hospital, Singapore	—
Completed	Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention a NCT00584298	Novartis	Phase 1
Completed	Study On The Effect Of GW876008 On Cerebral Blood Flow In Irritable Bowel Syndrome (IBS) Patients And Healthy NCT00376896	GlaxoSmithKline	Phase 1
Completed	Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowe NCT00421707	GlaxoSmithKline	Phase 2
Completed	A Study To Investigate The Effect Of Solabegron (GW427353) On Gastrointestinal Transit In Healthy Volunteers NCT00401479	GlaxoSmithKline	Phase 1
Completed	A Study To Investigate GW427353 In Subjects With Irritable Bowel Syndrome (IBS) NCT00394186	GlaxoSmithKline	Phase 2
Terminated	Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome NCT00316550	Avera Pharmaceuticals	Phase 1
Completed	Study to Determine the Effectiveness of the Probiotic E. Coli Strain M17 in Treating Irritable Bowel Syndrome NCT00194922	Weill Medical College of Cornell University	Phase 2
Completed	Study In Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy NCT00067457	GlaxoSmithKline	Phase 3
Completed	Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy NCT00067561	GlaxoSmithKline	Phase 3